Pharmacologic Controversy of CNS Stimulants in Gilles de la Touretteʼs Syndrome
- 1 October 1992
- journal article
- review article
- Published by Wolters Kluwer Health in Clinical Neuropharmacology
- Vol. 15 (5) , 408-425
- https://doi.org/10.1097/00002826-199210000-00010
Abstract
The controversy of the use of stimulants in Gilles de la Tourette's syndrome (GTS) can only be understood by examining the relationship between GTS and attention deficit-hyperactivity disorder (ADHD), because the relationship between the two disorders is complex, and stimulants are used in the one (ADHD) and may be contraindicated in the other (GTS). This relationship therefore has to be viewed from several perspectives, including clinical, genetic, neurobiochemical, neurophysiological, and treatment strategies, to highlight the complexities involved, and reasons for controversy. The present review will examine these relationships, and thus the evidence for and against the treatment of GTS with stimulants.Keywords
This publication has 38 references indexed in Scilit:
- Pemoline‐induced choreaNeurology, 1981
- Clonidine Ameliorates Gilles de la Tourette SyndromeArchives of General Psychiatry, 1980
- Familial Pattern of Gilles de la Tourette SyndromeArchives of General Psychiatry, 1980
- DextroamphetamineArchives of General Psychiatry, 1980
- Hyperkinetic Disorder in Psychiatric Clinic AttendersDevelopmental Medicine and Child Neurology, 1978
- Gilles de la Tourette's SyndromeArchives of Neurology, 1977
- A CONTROLLED STUDY OF SIBLINGS OF HYPERACTIVE CHILDRENJournal of Nervous & Mental Disease, 1977
- A REVIEW OF STIMULANT DRUG RESEARCH WITH HYPERACTIVE CHILDRENJournal of Child Psychology and Psychiatry, 1977
- Persistent Dyskinesias Following Phenothiazine TherapyArchives of Neurology, 1966
- BENZEDRINE® AND DEXEDRINE® IN THE TREATMENT OF CHILDREN'S BEHAVIOR DISORDERSPediatrics, 1950